Abstract:figure legend Skeletal muscle biopsies were taken from the vastus lateralis of 16 non‐athletes, non‐obese and non‐diabetic males between 8 and 9 a.m. In these biopsies we evaluated whether, similar to mouse genetic models, a diminished BMAL1 or CLOCK protein mass is accompanied by whole‐body metabolic alterations, altered mitochondrial dynamics, lower protein synthesis and reduced muscle strength. The mitochondria morphology, mitochondria ultrastructure, and the interaction between mitochondria and sarcoplasmic reticulum (mitochondria‐SR) were evaluated by electron microscopy. The protein abundance of the OXPHOS complex, mitochondria fusion/fission regulators, mitophagy and signalling proteins related to muscle protein synthesis were evaluated by western blot. Moreover, SkM cross‐sectional area and maximal SkM strength were evaluated. Lower BMAL1 protein mass was associated with smaller intermiofibrillar mitochondria, longer distance between mitochondria and SR, lower mitochondria cristae density and lower levels of the mTOR protein. On the other hand, lower CLOCK protein mass was associated with increased mitochondria–SR interaction, lower levels of the mitochondria CIII, OPA1 and DRP1 protein and lower protein synthesis signalling pathway (total mTOR, AKT, and P70S6K proteins), as well as lower SkM strength. Murine models lacking CLOCK/BMAL1 proteins in skeletal muscle (SkM) present muscle deterioration and mitochondria abnormalities. It is unclear whether humans with lower levels of these proteins in the SkM have similar alterations. Here we evaluated the association between BMAL1 and CLOCK protein mass with mitochondrial dynamics parameters and molecular and functional SkM quality markers in males. SkM biopsies were taken from the vastus lateralis of 16 male (non‐athletes, non‐obese and non‐diabetic) subjects (8–9 a.m.). The morphology of mitochondria and their interaction with the sarcoplasmic reticulum (mitochondria‐SR) were determined using transmission electron microscopy images. Additionally, protein abundance of the OXPHOS complex, mitochondria fusion/fission regulators, mitophagy and signalling proteins related to muscle protein synthesis were measured. To evaluate the quality of SkM, the cross‐sectional area and maximal SkM strength were also measured. The results showed that BMAL1 protein mass was positively associated with mitochondria‐SR distance, mitochondria size, mitochondria cristae density and mTOR protein mass. On the other hand, CLOCK protein mass was negatively associated with mitochondria‐SR interaction, but positively associated with mitochondria complex III, OPA1 and DRP1 protein mass. Furthermore, CLOCK protein mass was positively associated with the protein synthesis signalling pathway (total mTOR, AKT and P70S6K protein mass) and SkM strength. These findings suggest that the BMAL1 and CLOCK proteins play different roles in regulating mitochondrial dynamics and SkM function in males, and that modulation of these proteins could be a potential therapeutic target for treating muscle diseases. Key points In murine models, reductions in BMAL1 and CLOCK proteins lead to changes in mitochondria biology and a decline in muscle function. However, this association has not been explored in humans. We found that in human skeletal muscle, a decrease in BMAL1 protein mass is linked to smaller intermyofibrillar mitochondria, lower mitochondria cristae density, higher interaction between mitochondria and sarcoplasmic reticulum, and reduced mTOR protein mass. Additionally, we found that a decrease in CLOCK protein mass is associated with a higher interaction between mitochondria and sarcoplasmic reticulum, lower protein mass of OPA1 and DRP1, which regulates mitochondria fusion and fission, lower protein synthesis signalling pathway (mTOR, AKT and P70S6K protein mass), and decreased skeletal muscle strength. According to our findings in humans, which are supported by previous studies in animals, the mitochondrial dynamics and skeletal muscle function could be regulated differently by BMAL1 and CLOCK proteins. As a result, targeting the modulation of these proteins could be a potential therapeutic approach for treating muscle diseases and metabolic disorders related to muscle.

Apparent Absence of BMAL1-Dependent Skeletal Muscle-Kidney Cross Talk in Mice

Targeted Bmal1 restoration in muscle prolongs lifespan with systemic health effects in aging model

Male kidney-specific BMAL1 knockout mice are protected from Potassium-deficient, high salt diet-induced blood pressure increases.

Skeletal muscle BMAL1 is necessary for transcriptional adaptation of local and peripheral tissues in response to endurance exercise training

Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis

Circadian clock protein BMAL1 regulates cellular senescence in vivo

Sex differences in the adrenal circadian clock: A role for BMAL1 in the regulation of urinary aldosterone excretion and renal electrolyte balance in mice

Environmental Circadian Disruption Alters Body Composition and Impairs Energy Expenditure Rhythm Dependent on the Clock Gene, Bmal1

BMAL1 and CLOCK proteins exhibit differential association with mitochondrial dynamics, protein synthesis pathways and muscle strength in human muscle

Postnatal Deletion of Bmal1 in Mice Protects Against Obstructive Renal Fibrosis Via Suppressing Gli2 Transcription.

The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle

CLOCK and BMAL1 Regulate Muscle Insulin Sensitivity Via SIRT1 in Male Mice

Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function

Age-related BMAL1 Change Affects Mouse Bone Marrow Stromal Cell Proliferation and Osteo-Differentiation Potential.

Loss of endogenous circadian clock function in mice alters respiratory cycle timing in a time of day- and sex-specific manner

BMAL1 Regulates Osteoblast Differentiation Through Mtor/gsk3β/β-Catenin Pathway.

BMAL1 regulates osteoblast differentiation through mTOR/GSK3/-catenin pathway

Bmal1 Deletion in Mice Facilitates Adaptation to Disrupted Light/dark Conditions

Lack of Bmal1 leads to changes in rhythmicity and impairs motivation towards natural stimuli

Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness

Emerging Insight Into the Role of Circadian Clock Gene BMAL1 in Cellular Senescence